Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System.
Variables associated with patient activation in persons with multiple sclerosis.
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.
Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden.
Impact of intermittent catheterization on the quality of life of multiple sclerosis patients.
Assessing walking disability in multiple sclerosis.
Vitamin D Responsive Elements within the HLA-DRB1 Promoter Region in Sardinian Multiple Sclerosis Associated Alleles.
Does fatigue occur in MS patients without disability? Suggested running head: Fatigue and disability in MS.
Reward responsiveness and fatigue in multiple sclerosis.
Genetic burden of common variants in progressive and bout-onset multiple sclerosis.
Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis.
Can we overcome the 'clinico-radiological paradox' in multiple sclerosis?
Behavioral interventions in multiple sclerosis: a biopsychosocial perspective.
The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.
Biomarkers in multiple sclerosis.
Multiplexing analysis of the polyspecific intrathecal immune response in multiple sclerosis.
New TYSABRI® data show earlier treatment and longer-term use result in significant reductions in MS disease activity
Alteration of CD1 expression in multiple sclerosis.
Evaluating the potential benefit of interferon treatment in multiple sclerosis.
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.
Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis.
miR-15a and 16-1 are downregulated in CD4(+) T cells of multiple sclerosis relapsing patients.
AMP-Activated Protein Kinase Restricts IFN-γ Signaling.
Distraction adds to the cognitive burden in multiple sclerosis.
Association of SNPs rs6498169 and rs10984447 with multiple sclerosis in Saudi Patients: a model of the usefulness of familial aggregates in identifying genetic linkage in a multifactorial disease.
Pages
« first
‹ previous
…
139
140
141
142
143
144
145
146
147
…
next ›
last »